CORRECTED-BRIEF-Vertex Pharmaceuticals Q1 Revenue USD 2,770 Million Vs. IBES Estimate USD 2,853 Million

Reuters

2025/05/06

May 05 (Reuters) - Vertex Pharmaceuticals Q1 pretax profit USD 730.4 million vs. IBES estimate USD 1,368 million.

Q1 adjusted operating income USD 1,183 million vs. IBES estimate USD 1,254 million
Q1 adjusted net income USD 1,100 million vs. IBES estimate USD 1,134 million
Q1 operating income USD 630.1 million
Q1 net income USD 646.3 million
OUTLOOK FY TOTAL REVENUE USD 11,850-12,000 MILLION

應版權方要求，你需要登入查看該內容

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2533655055"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533655055\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533655055?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-06 04:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533655055","market":"nz","top_or_hot":-1,"title":"CORRECTED-BRIEF-Vertex Pharmaceuticals Q1 Revenue USD 2,770 Million Vs. IBES Estimate USD 2,853 Million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\">\n<head>\n<meta/>\n<title>CORRECTED-BRIEF-Vertex Pharmaceuticals Q1 Revenue USD 2,770 Million Vs. IBES Estimate USD 2,853 Million</title>\n</head>\n<body>\n<p>May 05 (Reuters) - Vertex Pharmaceuticals Q1 pretax profit USD 730.4 million vs. IBES estimate USD 1,368 million.</p>\n<ul>\n<li>Q1 adjusted operating income USD 1,183 million vs. IBES estimate USD 1,254 million</li>\n<li>Q1 adjusted net income USD 1,100 million vs. IBES estimate USD 1,134 million</li>\n<li>Q1 operating income USD 630.1 million</li>\n<li>Q1 net income USD 646.3 million</li>\n<li>OUTLOOK FY TOTAL REVENUE USD 11,850-12,000 MILLION</li>\n</ul>\n</body>\n</html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CORRECTED-BRIEF-Vertex Pharmaceuticals Q1 Revenue USD 2,770 Million Vs. IBES Estimate USD 2,853 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCORRECTED-BRIEF-Vertex Pharmaceuticals Q1 Revenue USD 2,770 Million Vs. IBES Estimate USD 2,853 Million\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-05-06 04:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\">\n<head>\n<meta/>\n<title>CORRECTED-BRIEF-Vertex Pharmaceuticals Q1 Revenue USD 2,770 Million Vs. IBES Estimate USD 2,853 Million</title>\n</head>\n<body>\n<p>May 05 (Reuters) - Vertex Pharmaceuticals Q1 pretax profit USD 730.4 million vs. IBES estimate USD 1,368 million.</p>\n<ul>\n<li>Q1 adjusted operating income USD 1,183 million vs. IBES estimate USD 1,254 million</li>\n<li>Q1 adjusted net income USD 1,100 million vs. IBES estimate USD 1,134 million</li>\n<li>Q1 operating income USD 630.1 million</li>\n<li>Q1 net income USD 646.3 million</li>\n<li>OUTLOOK FY TOTAL REVENUE USD 11,850-12,000 MILLION</li>\n</ul>\n</body>\n</html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VRTX","symbol_name":"福泰製藥","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLX01E3EA:1","article_id":"2533655055","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533655055","pubTimestamp":1746475305,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"May 05  - Vertex Pharmaceuticals Q1 pretax profit USD 730.4 million vs. IBES estimate USD 1,368 million.Q1 adjusted operating income USD 1,183 million vs. IBES estimate USD 1,254 million. Q1 adjusted net income USD 1,100 million vs. IBES estimate USD 1,134 million","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"VRTX":"福泰制药"},"translate_title":"简介-Vertex Pharmaceuticals第一季度收入为27.602亿美元，而IBES预估为28.53亿美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VRTX":0.9},"content_text":"CORRECTED-BRIEF-Vertex Pharmaceuticals Q1 Revenue USD 2,770 Million Vs. IBES Estimate USD 2,853 Million\n\n\nMay 05 (Reuters) - Vertex Pharmaceuticals Q1 pretax profit USD 730.4 million vs. IBES estimate USD 1,368 million.\n\nQ1 adjusted operating income USD 1,183 million vs. IBES estimate USD 1,254 million\nQ1 adjusted net income USD 1,100 million vs. IBES estimate USD 1,134 million\nQ1 operating income USD 630.1 million\nQ1 net income USD 646.3 million\nOUTLOOK FY TOTAL REVENUE USD 11,850-12,000 MILLION","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}